Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Program to reduce opioid use in chronic pain patients after surgery

Official title: Ontario Transitional Pain and Opioid Safety Program: Improving Pain and Opioid Practices for Complex Chronic Pain Patients Following Surgery

Run by University Health Network, Toronto · NCT03675386 · Data updated 2026-11-12

This study is testing a new program to help chronic pain patients use less opioids after surgery by providing pain education and support tools.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment210 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedOctober 15, 2018
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedApril 30, 2026
Trial IDNCT03675386 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are taking 20 to 200 mg of oral morphine equivalents daily and are scheduled for a surgical procedure.

Probably not a fit

Patients undergoing palliative care, organ transplantation, or those prescribed Methadone/Buprenorphine may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to help chronic pain patients who are prescribed opioids manage their pain more effectively and reduce their reliance on these medications following surgery. The Toronto General Hospital has developed a multidisciplinary Transitional Pain Service Program (TPSP) that includes pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self-management tool. A multicenter randomized controlled trial will evaluate the effectiveness of the TPSP across six hospital sites in Ontario, targeting 210 patients currently using opioids. The study will also analyze healthcare utilization and gather qualitative insights from participants to inform future pain management policies.

Why it matters

Potential benefit: If successful, this program could significantly reduce opioid dependence and improve pain management for patients after surgery.

How similar studies have gone: Other studies have shown promise in similar approaches to opioid reduction and pain management, but this specific program is novel in its comprehensive multidisciplinary approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥ 18 years of age
* Taking 10 -- 400 mg of preoperative oral morphine equivalents daily
* Any type of surgical procedure, with the exception of those with palliative intent or organ transplantation
* Able to read and understand English as posed on the questionnaire surveys prior to informed consent
* Must be taking opioids for at least one month prior to their operation
* Must have a personal email address for the set-up of the Manage My Pain (MMP) App or online multimedia tool

Exclusion Criteria:

• Subjects who are undergoing palliative care or procedures, organ transplantation, or prescribed with Methadone/Buprenorphine will be excluded from the trial

Where it's running

  • Toronto General Hospital- University Health Network
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Karim Ladha, MD — Toronto General Hospital, University Health Network
  • Study coordinator: Karim Ladha, MD
  • Email: Karim.Ladha@uhn.ca
  • Phone: 416-719-0030

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.